M
Mariko Seishima
Researcher at Gifu University
Publications - 262
Citations - 4884
Mariko Seishima is an academic researcher from Gifu University. The author has contributed to research in topics: Dermatomyositis & Psoriasis. The author has an hindex of 32, co-authored 253 publications receiving 4217 citations.
Papers
More filters
Journal ArticleDOI
Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
Yasuhito Hamaguchi,Manabu Fujimoto,Takashi Matsushita,Kenzo Kaji,Kazuhiro Komura,Minoru Hasegawa,Masanari Kodera,Eiji Muroi,Keita Fujikawa,Mariko Seishima,Hidehiro Yamada,Ryo Yamada,Shinichi Sato,Kazuhiko Takehara,Masataka Kuwana +14 more
TL;DR: Identification of individual anti-ARS Abs is beneficial to define this rather homogeneous subset and to predict clinical outcomes within the “anti-synthetase syndrome.”
Journal ArticleDOI
Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.
Yasuhito Hamaguchi,Masataka Kuwana,Kana Hoshino,Minoru Hasegawa,Kenzo Kaji,Takashi Matsushita,Kazuhiro Komura,Motonobu Nakamura,Masanari Kodera,Norihiro Suga,Akira Higashi,Koji Ogusu,Kiyohiro Tsutsui,Akira Furusaki,Hiroshi Tanabe,Shunsuke Sasaoka,Yoshinao Muro,Mika Yoshikawa,Naoko Ishiguro,Masahiro Ayano,Eiji Muroi,Keita Fujikawa,Yukihiro Umeda,Masaaki Kawase,Eriko Mabuchi,Yoshihide Asano,Kinuyo Sodemoto,Mariko Seishima,Hidehiro Yamada,Shinichi Sato,Kazuhiko Takehara,Manabu Fujimoto +31 more
TL;DR: Dermatomyositis-specific Abs define clinically distinct subsets and are useful for predicting clinical outcomes in patients with DM.
Journal ArticleDOI
Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.
Manabu Fujimoto,Yasuhito Hamaguchi,Kenzo Kaji,Takashi Matsushita,Yuki Ichimura,Masanari Kodera,Naoko Ishiguro,Ikuko Ueda-Hayakawa,Yoshihide Asano,Fumihide Ogawa,Keita Fujikawa,Takuya Miyagi,Eriko Mabuchi,Kenji Hirose,Narihiro Akimoto,Naohito Hatta,Kiyohiro Tsutsui,Akira Higashi,Atsuyuki Igarashi,Mariko Seishima,Minoru Hasegawa,Kazuhiko Takehara +21 more
TL;DR: To identify the 140-kd autoantigen recognized by anti-155/140 autoantibodies that are associated with adult cancer-associated dermatomyositis and juvenile DM and to determine the clinical relevance of anti- 155/140 antibodies in a large cohort is determined.
Journal ArticleDOI
A randomized double-blind trial of intravenous immunoglobulin for pemphigus
Masayuki Amagai,Shigaku Ikeda,Hiroshi Shimizu,Hajime Iizuka,Katsumi Hanada,Setsuya Aiba,Fumio Kaneko,Seiichi Izaki,Kunihiko Tamaki,Zenro Ikezawa,Masahiro Takigawa,Mariko Seishima,Toshihiro Tanaka,Yoshiki Miyachi,Ichiro Katayama,Yuji Horiguchi,Sachiko Miyagawa,Fukumi Furukawa,Keiji Iwatsuki,Michihiro Hide,Yoshiki Tokura,Masutaka Furue,Takashi Hashimoto,Hironobu Ihn,Sakuhei Fujiwara,Takeji Nishikawa,Hideoki Ogawa,Yasuo Kitajima,Koji Hashimoto +28 more
TL;DR: Intravenous immunoglobulin (400 mg/kg/d for 5 d) in a single cycle is an effective and safe treatment for patients with pemphigus who are relatively resistant to systemic steroids.
Journal ArticleDOI
Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome
TL;DR: Reactivation of human herpesvirus (HHV)‐6 has been reported in patients with DIHS, and some other DIHS patients showed reactivation of cytomegalovirus (CMV) or Epstein–Barr virus (EBV).